1. Immobilized mouse EPHB6-His at 10 μg/ml (100 μl/well) can bind mouse EFNB1-Fc , The EC50 of mouse EFNB1-Fc is 0.12-0.28 μg/ml. 2. Immobilized mouse EPHB6-His at 10 μg/ml (100 μl/well) can bind mouse EFNB2-Fc , The EC50 of mouse EFNB2-Fc is 0.04-0.08 μg/ml.

EphB6 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 61.1 kDa and the accession number is O08644-1.

Mouse

HEK293 Cells

Mep,EPH receptor B6,Cekl

A DNA sequence encoding the mouse EPHB6 (O08644-1) (Met1-Ser587) was expressed with a C-terminal polyhistidine tag. Predicted N terminal: Leu 33

> 85 % as determined by SDS-PAGE

A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information.

It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.

Ephrins are divided into the ephrin-A (EFNA) class and the ephrin-B (EFNB) class based on their structures and sequence relationships. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. EphB6 is an unusual Eph receptor, lacking catalytic capacity due to alterations in its kinase domain. Interestingly, increased metastatic activity is associated with reduced EphB6 receptor expression in several tumor types, including breast cancer. This emphasizes the potential of EphB6 to act as a suppressor of cancer aggressiveness. EphB6 suppress cancer invasiveness through c-Cbl-dependent signaling, morphologic changes, and cell attachment and indicate that EphB6 may represent a useful prognostic marker and a promising target for therapeutic approaches. EphB6 can both positively and negatively regulate cell adhesion and migration, and suggest that tyrosine phosphorylation of the receptor by an Src family kinase acts as the molecular switch for the functional transition. In addition, Ephrin-B2 may be a physiological ligand for the EphB6 receptor.